Science 37 Holdings Performance
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
The entity has a beta of 0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Science 37's returns are expected to increase less than the market. However, during the bear market, the loss of holding Science 37 is expected to be smaller as well. Science 37 Holdings right now has a risk of 0.0%. Please validate Science 37 maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Science 37 will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Science 37 Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Science 37 is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 130.2 M | |
| Free Cash Flow | -73.7 M |
Science |
Science 37 Relative Risk vs. Return Landscape
If you would invest 28.00 in Science 37 Holdings on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Science 37 Holdings or generate 0.0% return on investment over 90 days. Science 37 Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Science, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Science 37 Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Science 37's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Science 37 Holdings, and traders can use it to determine the average amount a Science 37's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SNCE |
Based on monthly moving average Science 37 is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Science 37 by adding Science 37 to a well-diversified portfolio.
Science 37 Fundamentals Growth
Science Stock prices reflect investors' perceptions of the future prospects and financial health of Science 37, and Science 37 fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Science Stock performance.
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 60.26 M | |||
| EBITDA | (59.86 M) | |||
| Cash And Equivalents | 130.24 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 8.69 X | |||
| Cash Flow From Operations | (48.19 M) | |||
| Earnings Per Share | (21.40) X | |||
| Total Asset | 126.45 M | |||
| Retained Earnings | (253.07 M) | |||
About Science 37 Performance
By analyzing Science 37's fundamental ratios, stakeholders can gain valuable insights into Science 37's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Science 37 has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Science 37 has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people.Things to note about Science 37 Holdings performance evaluation
Checking the ongoing alerts about Science 37 for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Science 37 Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Science 37 Holdings is not yet fully synchronised with the market data | |
| Science 37 Holdings has some characteristics of a very speculative penny stock | |
| Science 37 Holdings has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 60.26 M. Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 20.07 M. | |
| Science 37 Holdings currently holds about 130.24 M in cash with (48.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Science 37's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Science 37's stock is overvalued or undervalued compared to its peers.
- Examining Science 37's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Science 37's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Science 37's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Science 37's stock. These opinions can provide insight into Science 37's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |